Companies/MedMira Inc.

Company profile

MedMira Inc.

OTC: MMIRF · Healthcare · Biotechnology

Canadian filerHQ Halifax, NSReports USD

#1000 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

31D

FH 28DQ —GM 27SS 58

v0.1 · 45/100 weight · provisional

↑ Piotroski F, listing tenure · ↓ balance-sheet leverage, 3-yr revenue growth

Methodology →

Revenue TTM

$269.5k

Rev growth YoY (TTM)

+47.8%

Net income (FY)

-$3.2M

Employees

Market cap

$34.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$172.4k240.5k CAD2025

Net income-$3.2M-4.5M CAD2025

Operating income-$2.6M-3.6M CAD2025

Total assets$2.7M3.7M CAD2025

Liabilities$13.7M18.9M CAD2025

Equity-$16.3M-22.6M CAD2025

Revenue trend

FY2018 – FY2025 · USD

$462.3k

FY18

$398.6k

FY19

$682.8k

FY20

$1.7M

FY21

$750.2k

FY22

$322.3k

FY23

$303.5k

FY24

$172.4k

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

MedMira Inc. booked $172.4k in FY2025 revenue, contracting 43% year over year — slower than 80% of Healthcare companies we track, at a -1881.2% net margin.

Peers · Healthcare

LeonaBio, Inc.——RenovoRx, Inc.32D Dyadic International, Inc.39D Aligos Therapeutics, Inc.47D

Key facts

CEOHermes Chan

SectorHealthcare

IndustryBiotechnology

HeadquartersHalifax, NS

ExchangeOTC: MMIRF

Employees52

IPO date2009-11-03

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.